Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}}, 'protocolSection': {'designModule': {'phases': ['NA'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'DOUBLE', 'whoMasked': ['PARTICIPANT', 'OUTCOMES_ASSESSOR']}, 'primaryPurpose': 'PREVENTION', 'interventionModel': 'PARALLEL', 'interventionModelDescription': 'Randomized controlled superiority trial'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 40}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2020-11-26', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2020-12', 'completionDateStruct': {'date': '2020-12-17', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2020-12-19', 'studyFirstSubmitDate': '2020-10-07', 'studyFirstSubmitQcDate': '2020-10-07', 'lastUpdatePostDateStruct': {'date': '2020-12-22', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2020-10-14', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2020-12-17', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'incidence of postoperative hypotension', 'timeFrame': 'postoperative hour 2', 'description': 'Percentage of treatment period spent with a MAP \\< 65 mmHg'}], 'secondaryOutcomes': [{'measure': 'Number of vasopressor infusion rate modifications', 'timeFrame': 'postoperative hour 2', 'description': 'Number of vasopressor infusion rate modifications'}, {'measure': 'Amount of vasopressor', 'timeFrame': 'postoperative hour 2', 'description': 'Amount of noradrenaline received during surgery'}, {'measure': 'amount of fluid', 'timeFrame': 'postoperative hour 2', 'description': 'amount of fluid received during surgery'}, {'measure': 'incidence of acute kidney injury', 'timeFrame': 'postoperative day 7', 'description': 'incidence of acute kidney injury at postoperative day 7'}, {'measure': 'troponin values', 'timeFrame': 'postoperative day 0', 'description': 'troponin values at intensive care arrival'}, {'measure': 'troponin values', 'timeFrame': 'postoperative day 1', 'description': 'troponin values at postoperative day 1'}]}, 'oversightModule': {'oversightHasDmc': False, 'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'conditions': ['Cardiac Surgery']}, 'referencesModule': {'references': [{'pmid': '35061635', 'type': 'DERIVED', 'citation': 'Desebbe O, Rinehart J, Van der Linden P, Cannesson M, Delannoy B, Vigneron M, Curtil A, Hautin E, Vincent JL, Duranteau J, Joosten A. Control of Postoperative Hypotension Using a Closed-Loop System for Norepinephrine Infusion in Patients After Cardiac Surgery: A Randomized Trial. Anesth Analg. 2022 May 1;134(5):964-973. doi: 10.1213/ANE.0000000000005888.'}]}, 'descriptionModule': {'briefSummary': 'The investigators have developed an automated vasopressor controller to improve the titration of vasopressor in order to maintain mean arterial pressure (MAP) within a narrow range and have recently shown the controller was effective in both the operating room and intensive care unit. The controller has been used recently in a case series of three patients undergoing cardiac surgery and in five patients after cardiac surgery.\n\nThe investigators want to compare now a manual to a closed-loop titration of vasopressor infusion in patients admitted in the Intensive Care unit after cardiac surgery', 'detailedDescription': 'Perioperative hypotension and arterial pressure variability have been shown to negatively impact patient outcomes, increasing risk of stroke, kidney injury, and myocardial injury among others.\n\nVasopressors are usually used to rapidly correct hypotension. Vasopressor infusions are typically administered by standard infusion pump with the rate adjusted by anesthesiologists to reach a predefined target mean arterial pressure (MAP); this requires frequent changes in the infusion rate because of the almost constantly changing hemodynamic status of such patients. Because it is infeasible for human providers to pay constant attention and make second-to-second changes, management is often suboptimal (i.e. large amounts of time are spent in hypotension below the target, or well above the target with the vasopressor drip still running).\n\nThe investigators have developed an automated closed-loop vasopressor (CLV) controller to improve the titration of vasopressor (e.g:noradrenaline) in order to maintain MAP within a narrow range in the perioperative setting. The investigators have published engineering, animal and most recently, pilot,studies or case series with promising results.\n\nIn this randomized controlled trial, the investigators will compare time spent in hypotension defined as a mean arterial pressure \\< 65 mmHg. They tested the hypothesis that the automated system will allow patients to spent less time during the postoperative period with a MAP \\< 65 mmHg. This is thus a superiority study over a two hours study period'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'maximumAge': '90 Years', 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Adult patient\n* Elective cardiac surgery\n* French speaking patient\n\nExclusion Criteria:\n\n* Uncontrolled hypertension\n* Renal insufficiency (estimated glomerular filtration rate \\< 30mL/min/1,73m²)\n* Left ejection fraction \\< 40%\n* Emergency surgery\n* Preoperative infection\n* Preoperative cardiac arrythmia\n* Pregnant women'}, 'identificationModule': {'nctId': 'NCT04586218', 'acronym': 'COMAP', 'briefTitle': 'Controling Mean Arterial Pressure Using a Closed-Loop System for Vasopressor Titration', 'organization': {'class': 'OTHER', 'fullName': 'Clinique de la Sauvegarde'}, 'officialTitle': 'Postoperative Hypotension Management With Computer-guided Vasopressor Titration in High-Risk Patients After Cardiac Surgery: A Randomized Controlled Trial', 'orgStudyIdInfo': {'id': '2019-A03191-56'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'ACTIVE_COMPARATOR', 'label': 'Manual control of vasopressor infusion', 'description': 'Vasopressor will be manually titrated by intensive care unit nurses in charge of the patients to maintain mean arterial pressure \\> 65 mmHg.\n\nFluid administration consists in optimization of stroke volume (assisted fluid management) during the postoperative period', 'interventionNames': ['Behavioral: Manual control of vasopressor infusion']}, {'type': 'EXPERIMENTAL', 'label': 'Computer guided vasopressor infusion', 'description': 'Vasopressor will be titrated automatically by the closed-loop system to maintain mean arterial pressure \\> 65 mmHg.\n\nFluid administration consists in optimization of stroke volume (assisted fluid management) during the postoperative period', 'interventionNames': ['Behavioral: Computer guided vasopressor infusion']}], 'interventions': [{'name': 'Computer guided vasopressor infusion', 'type': 'BEHAVIORAL', 'description': 'automated titration of vasopressor infusion to maintain a mean arterial pressure \\> 65mmHg', 'armGroupLabels': ['Computer guided vasopressor infusion']}, {'name': 'Manual control of vasopressor infusion', 'type': 'BEHAVIORAL', 'description': 'manual adjustments of noradrenaline infusion', 'armGroupLabels': ['Manual control of vasopressor infusion']}]}, 'contactsLocationsModule': {'locations': [{'zip': '69009', 'city': 'Lyon', 'country': 'France', 'facility': 'Clinique de la Sauvegarde', 'geoPoint': {'lat': 45.74906, 'lon': 4.84789}}], 'overallOfficials': [{'name': 'Olivier Desebbe, MD', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Clinique de la Sauvegarde'}]}, 'ipdSharingStatementModule': {'ipdSharing': 'NO'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Clinique de la Sauvegarde', 'class': 'OTHER'}, 'collaborators': [{'name': 'Bicetre Hospital', 'class': 'OTHER'}, {'name': 'Erasme University Hospital', 'class': 'OTHER'}], 'responsibleParty': {'type': 'SPONSOR'}}}}